Compare PYXS & OWLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PYXS | OWLT |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.3M | 148.4M |
| IPO Year | 2021 | 2020 |
| Metric | PYXS | OWLT |
|---|---|---|
| Price | $1.69 | $4.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | $8.67 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 1.1M | 112.3K |
| Earning Date | 11-02-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $13,858,000.00 | ★ $105,708,000.00 |
| Revenue This Year | N/A | $13.29 |
| Revenue Next Year | $14,188.99 | $20.39 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 35.43 |
| 52 Week Low | $1.03 | $4.09 |
| 52 Week High | $5.55 | $16.94 |
| Indicator | PYXS | OWLT |
|---|---|---|
| Relative Strength Index (RSI) | 29.64 | 33.08 |
| Support Level | $1.58 | N/A |
| Resistance Level | $1.69 | $6.08 |
| Average True Range (ATR) | 0.12 | 0.21 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 9.32 | 9.09 |
Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma. Its product candidate, micvotabart pelidotin (MICVO, formerly PYX-201), is an investigational antibody-drug conjugate that targets extradomain-B fibronectin (EDB+FN), a component of the tumor extracellular matrix that is expressed in tumors and minimally present in normal tissues. MICVO consists of a fully human monoclonal antibody linked to a microtubule inhibitor payload, designed to bind within the tumor microenvironment and release its payload to kill cancer cells directly, affect nearby cells through a bystander effect, and induce immunogenic cell death, supporting enhanced anti-tumor activity.
Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.